The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis
Open accessAbstract
Key Points: Children treated for ALL without cranial radiation display significant IQ deficits of 6 to 8 points compared with healthy controls. Moderate deficits occur in other neurocognitive domains including working memory, information processing speed, and fine motor functioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neurocognitive and behavioral late effects include weaknesses in working memory, visual‐spatial reasoning, motor coordination, processing speed, and attention (Campbell et al., 2009; Iyer, Balsamo, Bracken, & Kadan‐lottick, 2015; Jacola et al., 2016; Peterson et al., 2008).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Iyer, Balsamo, Bracken, & Kadan‐lottick, 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
(2000) · Cited by 9,198
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
The Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417
Publication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291
The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics
Harris, A. D., McGregor, J. C., Perencevich, E. N., Furuno, J. P., Zhu, J., Peterson, D. E., & Finkelstein, J. (2006) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1749 · Cited by 1,023 · cited 1×
“Intelligence is consideredan integrationofdifferent neurocognitive functions.(23) When studies reported results for multiple time points, the latest time point was analyzed.”
BackgroundExecutive functions and their disorders
Elliott, R. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.49 · Cited by 792
Research works printed but not linked: 1
- Higgins, Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2
Cited by
Sorted by citations
The mutational footprints of cancer therapies
Pich, O., Muiños, F., Lolkema, M. P., Steeghs, N., Gonzalez-Perez, A., & Lopez-Bigas, N. (2019) · Nature Genetics · doi:10.1038/s41588-019-0525-5 · Cited by 309
Lum, A., Wakefield, C. E., Donnan, B., Burns, M. A., Fardell, J. E., & Marshall, G. M. (2017) · Child: Care, Health and Development · doi:10.1111/cch.12475 · Cited by 221
Chow, E. J., Anderson, L., Baker, K. S., Bhatia, S., Guilcher, G. M. T., Huang, J. T., Pelletier, W., Perkins, J. L., Rivard, L., Schechter, T., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.01.023 · Cited by 201
Jacola, L. M., Krull, K. R., Pui, C.-H., Pei, D., Cheng, C., Reddick, W. E., & Conklin, H. M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3205 · Cited by 160
Childhood Leukemia and Primary Prevention
Whitehead, T. P., Metayer, C., Wiemels, J. L., Singer, A. W., & Miller, M. D. (2016) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2016.08.004 · Cited by 136
Metadata
- Authors
- Iyer, N. S., Balsamo, L. M., Bracken, M. B., & Kadan-Lottick, N. S.
- Affiliations
- Lake Erie College of Osteopathic Medicine (US)
- Yale Cancer Center (US)
- Yale University (US)
- Pediatric Hematology/Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2015-07-16
- Volume
- 126
- Issue
- 3
- Pages
- 346-353
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1888049586
- Cited by
- 194
- References
- 66
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 14 · 2023: 16 · 2022: 9 · 2021: 27 · 2020: 20 · 2019: 22 · 2018: 17 · 2017: 19 · 2016: 20 · 2015: 4
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- St. Baldrick's Foundation
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- childhood acute lymphoblastic leukemia, cognitive impairment, intelligence quotient, verbal IQ, performance IQ, working memory, processing speed, fine motor skills, cancer survivors
- MeSH terms
- Antineoplastic Combined Chemotherapy Protocols, Brain Neoplasms, Child, Cognition Disorders, Humans, Survival Rate, Survivors, Precursor Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
